Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PRAD | rs10198681 | chr2:178793793 | T/C | 4.13E-5 | 494 | 30.77 | 31.93 | 20.48 | KM Plot |
PRAD | rs10198877 | chr2:178794039 | T/G | 4.13E-5 | 494 | 30.77 | 31.93 | 20.48 | KM Plot |
PRAD | rs10201150 | chr2:178788069 | A/C | 4.15E-5 | 493 | 30.78 | 31.93 | 20.48 | KM Plot |
PRAD | rs10201731 | chr2:178794619 | T/G | 4.13E-5 | 494 | 30.77 | 31.93 | 20.48 | KM Plot |
PRAD | rs10202295 | chr2:232084411 | T/G | 7.83E-5 | 484 | 32.23 | 28.78 | 31.13 | KM Plot |
PRAD | rs10202813 | chr2:103019740 | A/C | 0.000153 | 494 | 26.18 | 30.12 | 32 | KM Plot |
PRAD | rs10208501 | chr2:178783330 | C/T | 4.15E-5 | 493 | 30.78 | 31.93 | 20.48 | KM Plot |
PRAD | rs10211341 | chr2:178783749 | G/A | 4.15E-5 | 493 | 30.78 | 31.93 | 20.48 | KM Plot |
PRAD | rs10221783 | chr2:178772345 | A/C | 3.83E-5 | 494 | 20.48 | 35.33 | 30.33 | KM Plot |
PRAD | rs10227931 | chr7:135084601 | C/T | 1.74E-9 | 493 | 30.8 | 31.9 | 3.03 | KM Plot |
PRAD | rs10235488 | chr7:135181037 | C/T | 1.88E-9 | 492 | 30.53 | 32.63 | 3.03 | KM Plot |
PRAD | rs10238568 | chr7:135122039 | G/C | 2.02E-9 | 492 | 30.77 | 32.4 | 3.03 | KM Plot |
PRAD | rs10239457 | chr7:135116926 | A/G | 2.34E-10 | 494 | 2.33 | 31.1 | 30.9 | KM Plot |
PRAD | rs10243569 | chr7:135063466 | G/A | 1.95E-9 | 491 | 30.8 | 31.9 | 3.03 | KM Plot |
PRAD | rs10251162 | chr7:135190264 | C/T | 2.02E-9 | 488 | 30.77 | 32.52 | 8.75 | KM Plot |